US pharmacy pricing
Exem Prices at US Pharmacies
Lowest price found · US pharmacies
$911.54/fill
for Exem, across the pharmacies in our data
US pharmacy prices — 10ml of 10ml
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $911.54Lowest | $914.54 | $317.63 | |
| $911.54Lowest | $914.54 | $317.63 | |
| $957.93 | $960.93 | $317.63 | |
| $963.67 | $966.67 | $317.63 | |
| $964.76 | $967.76 | $317.63 | |
| $979.01 | $982.01 | $317.63 | |
| $979.01 | $982.01 | $317.63 | |
| $984.08 | $987.08 | $317.63 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Frequently asked questions
How much does Exem (Exem) cost without insurance?
At the US pharmacies in our data, the lowest listed discount-card price for Exem is around $911.54. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Exem available?
Generic and brand-name pricing for Exem is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
What will I pay for ExEm if I have insurance coverage?
The cost of ExEm with insurance varies significantly depending on your specific plan's formulary, coverage tiers, and coinsurance or copay requirements. You should contact your insurance provider directly to confirm if ExEm is covered and to learn your exact out-of-pocket cost. If your plan does not cover this medication, or if your copay is high, you may want to compare that cost against prices available through pharmacy savings programs or discount cards. These alternative savings options can also be explored by individuals with Medicare or Medicaid plans if the medication is not covered by those programs.
Can I get a generic form of ExEm?
No. ExEm is currently only available as a brand-name drug manufactured by Exem Foam Inc. A generic equivalent has not been approved and is not on the market at this time.